Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 21 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 11220524

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  2. US 11213513

    Compositions and methods for promoting hair growth with Mpc1 inhibitors

    The Regents of the University of California · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  3. US 11214567

    Small molecule inhibitors of MYC and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  4. US 11214574

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  5. US 11208413

    Pyrimidopyrimidinones useful as wee-1 kinase inhibitors

    ALMAG DISCOVERY LIMITED · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  6. US 11208416

    Selective inhibitors of protein arginine methytransterase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  7. US 11208432

    Inhibitors of glucocorticoid receptor

    ORIC PHARMACEUTICALS, INC. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  8. US 11208405

    Pyrrole derivatives as PLK1 inhibitors

    SENTINEL ONCOLOGY LIMITED · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  9. US 11207314

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  10. US 11203574

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

  11. US 11203602

    Thioester prodrugs of macrocycles as inhibitors of histone deacetylases

    OnKure, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

  12. US 11203600

    Kinase inhibitors and uses thereof

    DENALI THERAPEUTICS INC. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

  13. US 11198691

    N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors

    KalVista Pharmaceuticals Limited · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  14. US 11198682

    Substituted pyrimidines as inhibitors for a Rho family of GTP-ases

    The Regents of the University of California · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  15. US 11198694

    HDAC6 inhibitors, with improved solubility and their uses

    Universität Regensburg · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  16. US 11191758

    Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors

    Uniwersytet Jagiellonski Collegium Medicum · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  17. US 11191750

    Use of mTOR inhibitors for treatment of familial adenomatous polyposis

    The Board of Regents of the University of Texas System · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  18. US 11192907

    Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same

    QUANTUM GENOMICS · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  19. US 11192861

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Dec 7, 2021 · Expires Dec 2, 2041

    granted

  20. US 11186576

    Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitors

    Aurigene Discovery Technologies Limited · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  21. US 11180483

    Substituted reverse pyrimidine Bmi-1 inhibitors

    PTC THERAPEUTICS, INC. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  22. US 11179400

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  23. US 11180499

    Phosphodiesterase inhibitors

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

  24. US 11180494

    Substituted amino acids as integrin inhibitors

    Pliant Therapeutics, Inc. · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.